2019 China Pharmaceutical Newcomer Award" - Wei You Jia and Wei Jin Chang

On December 3, 2019, the "10th Pharmaceutical Observer Emerging Forum" was held in Chongqing City, with nearly 1,000 participants including pharmaceutical-related government officials, pharmaceutical experts and scholars, entrepreneurs and pharmaceutical elites at large. The Marketing Department and Business Development Department of Wisepac attended the forum on behalf of the company.

With the theme of "Breaking and Standing in the Hardcore Era", the forum invited many industry experts and nearly 1,000 pharmaceutical elites to explore new paths and trends in China's pharmaceutical development, and to discuss new policies such as the new Drug Administration Law, the "4+7" quantity-based procurement, medical insurance catalogues and They discussed in depth the new policies, rules and patterns such as the new Drug Administration Law, "4+7" procurement with volume, medical insurance catalogue and payment rules, financial verification, etc.

The grand finale of the forum was the award ceremony of the "2019 China Pharmaceutical Newcomers List". (hereinafter referred to as "Inner Mongolia Baiyi Pharmaceutical Co., Ltd. "), a subsidiary of Tibet Weixinkang Pharmaceutical Co., Ltd.

, won the award for its two new products: Pediatric Multivitamins For Injection（13） and Acetylcysteine Solution For Inhalation. (hereinafter referred to as "Inner Mongolia Baiyi Pharmaceutical Co., Ltd. "), won the "2019 Most Competitive New Pediatric Drug Product" and "2019 Most Competitive New Respiratory Drug Product" respectively, which were recognized and expected by the general industry. Geng Hongwu, the initiator of China Pharmaceutical Alliance, and Guo Wei, a famous domestic tax expert and the third executive director of the China Association of Certified Tax Accountants, presented awards to the two outstanding brands respectively, while Liu Jie, Director of Medical Marketing Department, and Product Manager received the awards on behalf of the company on stage.

2019 marks the 10th year of the new medical reform. Facing the new situation of transformation and upgrading, the new environment of ever-changing policies and markets, as a growing Chinese pharmaceutical enterprise, Inner Mongolia Baiyi Pharmaceutical Co., Ltd. grandly launched the two most market-competitive outstanding products at this special time, becoming the shining brands that have been in the limelight since their launch, shining in the field of pediatrics and respiratory diseases respectively. WeiYuJia® is the first intravenous multivitamin for children approved in China. It is an excellent product with the recommended composition and content in line with the guidelines, and will be a better choice for clinical parenteral vitamin preparations in paediatrics. Wejin Chang® is a nebulised expectorant drug on the medical insurance list, with a comprehensive mechanism of action and flexible therapeutic options for both children and adults, which will bring better clinical choices. With the help of the industry's elite gathering, Inner Mongolia Baiyi Pharmaceutical Co., Ltd. has won industry recognition for its new brand and made more people in the industry aware of the power of growing companies. Inner Mongolia Baiyi Pharmaceutical Co., Ltd.will serve the clinic with the excellent quality of its products, so that more patients can benefit.